The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)

被引：0
|
作者：
Hayder M. Al-kuraishy
Ali I. Al-Gareeb
Hebatallah M. Saad
Gaber El-Saber Batiha
机构：
[1] Al-Mustansiriyah University,Department of Pharmacology, Toxicology and Medicine, Medical Faculty, College of Medicine
[2] Matrouh University,Department of Pathology, Faculty of Veterinary Medicine
[3] Damanhour University,Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine
来源：
Inflammopharmacology | 2023年 / 31卷
关键词：
Fibroblast growth factor 21; T2DM; Metformin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Fibroblast growth factor 21 (FGF21) is a peptide hormone mainly synthesized and released from the liver. FGF21 acts on FGF21 receptors (FGFRs) and β-Klotho, which is a transmembrane co-receptor. In type 2 diabetes mellitus (T2DM), inflammatory disorders stimulate the release of FGF21 to overcome insulin resistance (IR). FGF21 improves insulin sensitivity and glucose homeostasis. Metformin which is used in the management of T2DM may increase FGF21 expression. Accordingly, the objective of this review was to clarify the metformin effect on FGF21 in T2DM. FGF21 level and expression of FGF2Rs are dysregulated in T2DM due to the development of FGF21 resistance. Metformin stimulates the hepatic expression of FGF21/FGF2Rs by different signaling pathways. Besides, metformin improves the expression of β-Klotho which improves FGF21 sensitivity. In conclusion, metformin advances FGF21 signaling and decreases FGF21 resistance in T2DM, and this might be an innovative mechanism for metformin in the enhancement of glucose homeostasis and metabolic disorders in T2DM patients.
引用
收藏
页码：1751 / 1760
页数：9
相关论文
共 50 条
  • [21] Gut microbiota influence in type 2 diabetes mellitus (T2DM)
    Cunningham, A. L.
    Stephens, J. W.
    Harris, D. A.
    [J]. GUT PATHOGENS, 2021, 13 (01)
  • [22] Effects on lipid metabolism of metformin and troglitazone, alone and in combination, in patients with type 2 diabetes mellitus (T2DM)
    Lee, I
    Maggs, DG
    Katz, D
    Spollett, GR
    Page, SL
    Rife, FS
    Inzucchi, SE
    [J]. DIABETES, 2002, 51 : A105 - A105
  • [23] Combination of Saxagliptin and Metformin Is Effective as Initial Therapy in Type 2 Diabetes Mellitus (T2DM) With Severe Hyperglycemia
    Babu, Ambika
    Barcham, Samih
    Daniel, Louis
    Fogelfeld, Leon
    [J]. DIABETES, 2013, 62 : A273 - A273
  • [24] METFORMIN HAS A POSITIVE EFFECT IN TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS WITH SQUAMOUS CELL CARCINOMA (SCC) OF THE LARYNX OR OROPHARYNX
    Infield, J.
    Ogunsakin, A.
    Zuber, J.
    Solomon, S.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 615 - 615
  • [25] Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes
    Fan, Hui
    Sun, XiaoMeng
    Zhang, Heng
    Liu, Jia
    Zhang, PengRui
    Xu, Yuan
    Pan, QingRong
    Wang, Guang
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (03) : 120 - 126
  • [26] Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
    So, Wing Yan
    Leung, Po Sing
    [J]. MEDICINAL RESEARCH REVIEWS, 2016, 36 (04) : 672 - 704
  • [27] Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite?
    Malone, John I.
    Hansen, Barbara C.
    [J]. PEDIATRIC DIABETES, 2019, 20 (01) : 5 - 9
  • [28] Altered bile salt metabolism in type 2 diabetes mellitus (T2DM)
    Brufau, Gemma
    Kuipers, Folkert
    Prado, Kris
    Abbey, Stacey
    Jones, Michael
    Schwartz, Sherwyn
    Stellaard, Frans
    Murphy, Elizabeth
    [J]. DIABETES, 2008, 57 : A435 - A435
  • [29] Bayesian nonparametric comorbidity analysis of type 2 diabetes mellitus (T2DM)
    De la Torre, Adrian Martinez
    Perez-Cruz, Fernando
    Weiler, Stefan
    Burden, Andrea
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 503 - 504
  • [30] Alternate therapy of Type 2 diabetes mellitus (T2DM) with Nigella (Ranunculaceae)
    Akash, M. S. H.
    Rehman, K.
    Rasool, F.
    Sethi, A.
    Abrar, M. A.
    Irshad, A.
    Abid, A.
    Murtaza, G.
    [J]. JOURNAL OF MEDICINAL PLANTS RESEARCH, 2011, 5 (31): : 6885 - 6889
12345